Sphera Health
Israel’s First and Leading
Healthcare Hedge Fund
Arkin Capital has collaborated with Sphera Funds Management in the healthcare field for over two decades. Sphera Health delivers consistent, long-term, risk-adjusted returns, exceeding benchmarks while adhering to high international compliance and operational standards.
-
2
Health Funds Partnering With Sphera Funds Management
-
2007
First Collaborative Fund Was Founded
-
Strategy
Sphera Healthcare – Large Cap | Sphera Biotech – SMID
Arkin Capital and Sphera Health Funds
Sphera Global Healthcare
Sphera Global Healthcare is a partnership between Arkin and Sphera Funds Management, founded in 2007. It employs a long/short equity strategy focused on investments in the global pharmaceutical and biotechnology sectors. Sphera Global Healthcare’s investments are based on comprehensive scientific research conducted by a team of scientists, doctors, and investment experts operating in Tel Aviv. The team of analysts is organized by therapeutic category, allowing for deep insights and expertise in treatment modalities.
Sphera Biotech
Sphera Biotech is a partnership between Arkin and Sphera Funds Management, founded in 2018. This long/short equity strategy focuses on highly innovative small and mid-cap companies in the global biotechnology sector. Similar to SGH, Sphera Biotech’s investments are based on comprehensive scientific research conducted by teams of scientists, doctors, and investment experts operating in Tel Aviv. The investment team’s research process aims to use this enhanced perspective to detect disruptive technologies at an early stage.
Relationships That Resonate: Words from Our Partners
Let’s Get in Touch!